CVS Health (CVS) Tops Q2 EPS by 35c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $81.31 +1.69%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $1.81, $0.35 better than the analyst estimate of $1.46. Revenue for the quarter came in at $98.9 billion versus the consensus estimate of $94.73 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.30-$6.40, versus the consensus of $6.12.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Hudson Pacific Properties (HPP) Misses Q3 EPS by 265c
- Assurant (AIZ) PT Raised to $345 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
